News about awards and recognition earned by UB and members of our community. (see all topics)
The Austrian-based company, led by Gábor Somogyi, MBA ’03, develops unique vaccines.
The companies are developing treatments for cancer, neurovascular diseases and more.
UB is No. 38 among public universities, according to the rankings.
Researching the past could provide important insights into how climate change may impact ecosystems today.
Fellowship in the American College of Clinical Pharmacy recognizes excellence in the practice and science of clinical pharmacy.
Destination Dental School – a program that aims to remove barriers to careers in dentistry for underrepresented students – received the 2022 Inspiring Programs in STEM Award.
Aga, director of the UB RENEW Institute, is a globally recognized leader in environmental and analytical chemistry.
UB receives $4 million from NIAID to develop new treatments that prevent 'hypermutations' in antibiotic-resistant bacteria.
The care will be delivered through the UB S-Miles To Go program using the university’s mobile dental clinics.
The seven-year grant is the third contract awarded to UB to lead a clinical pharmacology quality assurance program for NIH-funded labs.
Get our news in your favorite channels. >> details
Take UB With You. Wherever.